Non-pharmacologic approaches to treatment of pediatric functional abdominal pain disorders

Partha Sarathi Chakraborty1, Rhea Daniel1, Fernando A Navarro1

  • 1Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, United States.

PubMed

Insights

Functional abdominal pain disorders (FAPDs) in children are linked to brain-gut interactions. This review explores non-pharmacologic treatments like diet, microbiome manipulation, and psychological therapies for FAPDs.

Area of Science:

  • Pediatric Gastroenterology
  • Neurogastroenterology
  • Brain-Gut Interactions

Background:

  • Functional abdominal pain disorders (FAPDs) affect up to 25% of US children.
  • FAPDs are increasingly understood as disorders of brain-gut interaction.
  • Pathophysiology involves gut motility, visceral hypersensitivity, microbiome dysbiosis, and psychological factors.

Purpose of the Study:

  • To review non-pharmacologic interventions for FAPDs in children.
  • To summarize dietary, microbiome-based, and psychological treatment approaches.
  • To highlight the need for evidence-based research on these therapies.

Main Methods:

  • Literature review of non-pharmacologic treatments for FAPDs.
  • Categorization of interventions into dietary, microbiome manipulation, and psychological approaches.
  • Inclusion of data from a survey on complementary and alternative medicine use.

Main Results:

  • Non-pharmacologic strategies include dietary changes, microbiome modulation (probiotics, prebiotics, FMT), and psychological therapies (CBT, hypnotherapy).
  • A significant majority (96%) of patients utilize complementary and alternative medicine.
  • Limited data exists to support the efficacy of many reviewed therapies.

Conclusions:

  • Non-pharmacologic interventions offer potential treatment avenues for pediatric FAPDs.
  • Further large-scale randomized controlled trials are essential to establish efficacy and guide clinical practice.
  • Addressing brain-gut axis components is crucial for managing FAPDs.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
225
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
217
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
245
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
113
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
248
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
155